Pharmaceutical Anti-Counterfeiting

Regular price €100.99
Quantity:
Delivery/Collection within 10-20 working days
Shipping & Delivery
A01=Mark Davison
anti-counterfeiting
Author_Mark Davison
Category=KJC
Category=KND
consumer protection
counterfeit drugs
counterfeit pharmaceuticals
eq_bestseller
eq_business-finance-law
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
fake drugs
fake pharmaceuticals
intellectual property protection
intellectual property security
knock-off medication
medical fraud
pharmaceutical security
sub-standard medication

Product details

  • ISBN 9780470616178
  • Weight: 821g
  • Dimensions: 164 x 240mm
  • Publication Date: 12 Aug 2011
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: US
  • Product Form: Hardback
Secure checkout Fast Shipping Easy returns
This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe.

MARK DAVISON, CEO of Blue Sphere Health, is a pharmaceutical consultant and entrepreneur with more than twenty years of industry experience. He was formerly business development director for healthcare at SICPA, one of the world's leading anti-counterfeiting and product security technology providers, where he gained an in- depth, global perspective on counterfeit pharmaceuticals and medical devices. He is a writer, seminar leader, and international conference speaker on pharmaceutical security matters. His article "Drugs for the Developing World: Obligation, Opportunity and Threat" won the Royal Society of Medicine Oswald Morton Essay Prize in 2010.

More from this author